CRBP
Corbus Pharmaceuticals HoldingNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$183.04M
P/E Ratio
—
EPS
$-5.90
Beta
2.79
52W High
$20.56
52W Low
$5.68
50-Day MA
$8.56
200-Day MA
$10.03
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Corbus Pharmaceuticals Holding
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of novel therapies that target the endocannabinoid system in the fields of autoimmunity, fibrosis, and cancer. The company is headquartered in Norwood, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-70.09M |
| EBITDA | $-85.08M |
| Operating Margin | 0.00% |
| Return on Equity | -54.20% |
| Return on Assets | -32.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $8.38 |
| Price-to-Book | 1.23 |
| Price-to-Sales (TTM) | 169.88 |
| EV/Revenue | 4531.61 |
| EV/EBITDA | 0.17 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $17.74M |
| Float | $12.74M |
| % Insiders | 0.59% |
| % Institutions | 75.82% |
Historical Volatility
HV 10-Day
84.66%
HV 20-Day
77.20%
HV 30-Day
86.23%
HV 60-Day
72.97%
HV Rank
75.4%
Volatility is currently contracting
Analyst Ratings
Consensus ($40.56 target)
2
Strong Buy8
BuyData last updated: 4/10/2026